Can we use mineralocorticoid receptor blockade in diabetic patients with resistant hypertension? Yes we can! But it may be a double-edged sword

J Hypertens. 2013 Oct;31(10):1948-51. doi: 10.1097/HJH.0b013e328364bcdf.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Blood Pressure / drug effects*
  • Diabetes Complications / drug therapy*
  • Female
  • Humans
  • Hypertension / drug therapy*
  • Male
  • Spironolactone / administration & dosage*
  • Spironolactone / therapeutic use*

Substances

  • Spironolactone